Table 2. Incidences of LOH of IGF2 in previous and present series of hepatoblastoma and Wilms' tumours.
| References | Total number | LOH of IGF2a | No-LOH of IGF2 | % |
|---|---|---|---|---|
| Hepatoblastoma | ||||
| Montagna et al (1994) | 13 | 3 | 10 | 23.1 |
| Fukuzawa et al (1999) | 7 | 2 | 5 | 28.6 |
| Gray et al (2000) | 10 | 2 | 8 | 20.0 |
| Hartmann et al (2000) | 24 | 6 | 18 | 25.0 |
| Albrecht et al (2004) | 56 | 13 | 43 | 23.2 |
| Suzuki et al (2008) | 17 | 4 | 13 | 23.5 |
| Total number | 127 | 30 | 97 | 23.6 |
| Present study | 54 | 12 | 42 | 22.2 |
| Wilms' tumour | ||||
| Grundy et al (1996) | 260 | 93 | 167 | 35.8 |
| Yuan et al (2005) | 62 | 26 | 36 | 41.9 |
a
Tumours with LOH of 11p15, but no informative IGF2 locus are included.